Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	147
Overall Study	STARTED	MEDI3506 30 mg	96
Overall Study	STARTED	MEDI3506 60 mg	101
Overall Study	STARTED	MEDI3506 120 mg	95
Overall Study	STARTED	MEDI3506 300 mg	160
Overall Study	COMPLETED	Placebo	99
Overall Study	COMPLETED	MEDI3506 30 mg	70
Overall Study	COMPLETED	MEDI3506 60 mg	70
Overall Study	COMPLETED	MEDI3506 120 mg	68
Overall Study	COMPLETED	MEDI3506 300 mg	120
Overall Study	NOT COMPLETED	Placebo	48
Overall Study	NOT COMPLETED	MEDI3506 30 mg	26
Overall Study	NOT COMPLETED	MEDI3506 60 mg	31
Overall Study	NOT COMPLETED	MEDI3506 120 mg	27
Overall Study	NOT COMPLETED	MEDI3506 300 mg	40

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04170543/flow